SL
CLB icon

Salomon & Ludwin’s Core Laboratories CLB Stock Holding History

Salomon & Ludwin’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.67K Hold
347
– – ﹤0.01% 1736
2025
Q4 		$6.29K Buy
+347
New +$5.17K ﹤0.01% 1690

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Salomon & Ludwin's CLB Position: Q1 2026 in Review

Salomon & Ludwin held its Core Laboratories (CLB) position steady in Q1 2026 at 347 shares worth $5.67K. The position accounts for ﹤0.01% of the portfolio, ranked #1736.

Salomon & Ludwin first reported a position in CLB in Q4 2025 and has held it in 2 quarters since. The position peaked at $6.29K in Q4 2025. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Salomon & Ludwin held 347 shares of Core Laboratories worth $5.67K as of Q1 2026.
  • Salomon & Ludwin left its Core Laboratories share count unchanged in Q1 2026.
  • Core Laboratories made up ﹤0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #1736 holding.
  • Salomon & Ludwin first reported a position in Core Laboratories in Q4 2025 and has held it in 2 quarters since.
  • Salomon & Ludwin's Core Laboratories position peaked at $6.29K in Q4 2025.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.